Back to search

France· FR:68569606

ACIDE CARGLUMIQUE TILLOMED 200 mg, comprimé dispersible sécable

A medicinal product, registered in France by TILLOMED PHARMA (ALLEMAGNE).

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedACIDE CARGLUMIQUE TILLOMED 200 mg, co…ATC—REGISTER NO.FR:68569606PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Manufacturer
TILLOMED PHARMA (ALLEMAGNE)
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955094845
    60 plaquettes prédécoupées unitaires aluminium OPA : polyamide orienté PVC de 1 comprimé

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

ACIDE in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ACIDE products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Carglumsäure Waymade
  • Czechia · Carglumic Acid
  • Germany · Carglumsäure Waymade, Carglumsäure Zentiva
  • Denmark · Cargluminsyre
  • Spain · Ácido Carglúmico, Ácido Carglúmico Tillomed
  • Finland · Karglumiinihappo Waymade
  • United Kingdom (Northern Ireland) · Carglumic Acid Waymade
  • Greece · Carglumic Acid, Carglumic Acid Tillomed
  • Iceland · Carbaglu, Ucedane
  • Italy · Acido Carglumico Waymade
  • Liechtenstein · Carbaglu, Ucedane
  • Netherlands · Carglumaatzuur Tillomed, Carglumaatzuur Waymade
  • Norway · Carbaglu, Kargluminsyre Waymade
  • Poland · Kwas Kargluminowy
  • Portugal · Ácido Carglúmico, Ácido Carglúmico Waymade
  • Sweden · Kargluminsyra Waymade

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/339a46ac-d8cd-48c7-a801-8165414f5b5d
GET /v1/drugs/339a46ac-d8cd-48c7-a801-8165414f5b5d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68569606",
  "date_amm": "2023-03-20",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé dispersible sécable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ACIDE.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.